Good results for Merck's Sperm Quality Analyser (SQA):
This article was originally published in Clinica
Executive Summary
German company Merck KGaA's Sperm Quality Analyser performed well in a study at the Royal Surrey County Hospital in Guildford, UK, against WHO quality criteria. The study involved 50 measurements on a range of semen samples, including patients receiving chemotherapy, those who had undergone vasectomy and patients whose partners were undergoing intra-uterine insemination. Each sample was tested four times, with a mean SMI value taken. The SQA provides results in around 40 seconds, giving digital readings of the sperm motility index in three parameters: total concentration, percent motility and abnormal morphology.